← Browse by Condition
Medical Condition
aplastic anemia
Total Trials
5
Recruiting Now
5
Trial Phases
EARLY_Phase 1, Phase 2
NCT06633328 EARLY_Phase 1
Recruiting
CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia
Enrollment
30 pts
Location
China
Sponsor
Zhejiang University
NCT05031897 Phase 2
Recruiting
Two Step Haplo With Radiation Conditioning
Enrollment
63 pts
Location
United States
Sponsor
Thomas Jefferson University
NCT01624805 Phase 2
Recruiting
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
Enrollment
140 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06613880 Phase 2
Recruiting
Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia
Enrollment
48 pts
Location
China
Sponsor
Institute of Hematology & Bloo...
NCT05194397 Phase 2
Recruiting
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
Enrollment
80 pts
Location
United States
Sponsor
Children's Hospital of Philade...